Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung

BACKGROUND: Uncontrolled inflammation is a central problem for many respiratory diseases. The development of potent, targeted anti-inflammatory therapies to reduce lung inflammation and re-establish the homeostasis in the respiratory tract is still a challenge. Previously, we developed a unique anti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nanobiotechnology
Autors principals: Wang, Lu, Rao, Yafei, Liu, Xiali, Sun, Liya, Gong, Jiameng, Zhang, Huasheng, Shen, Lei, Bao, Aihua, Yang, Hong
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905431/
https://ncbi.nlm.nih.gov/pubmed/33632244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00803-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars